Habib Belaid, founder of Kervalion, a company developing an innovative 3D-printed bone graft solution for dental surgeons, shares his experience with Strategic Challenge, Eurobiomed's support program that combines the expertise of its team and its network.
How did the initial needs assessment phase with Eurobiomed unfold?
The first step was crucial, involving the establishment of precise specifications. We develop medical devices for dental surgery, and it was essential to clearly define our regulatory requirements, both European and American.
Eurobiomed supported us during this phase to ensure that the selected service providers precisely matched our industry sector and specific challenges.
How did Eurobiomed's support facilitate your approach?
The time savings were considerable. Without this support, we would have had to undertake the entire benchmarking process for consulting firms ourselves, and then challenge them individually.
Eurobiomed's expertise in selecting service providers allowed us direct access to qualified and relevant firms for our project. This approach saved us several weeks in our selection process.
What was the concrete impact on your corporate strategy?
This collaboration provided us with essential certainties for our development. Thanks to Strategic Challenge, we were able to precisely define the classification of our medical device and identify the applicable standards.
We also gained a clear understanding of the timelines and costs associated with our regulatory development. This initial phase truly served as a springboard for our subsequent regulatory development.
